This laboratory has proposed that endogenous gut-derived bacterial endotoxin primes the pancreatic secretion of insulin in normal rats. Endogenous lipopolysaccharide (LPS) is continually absorbed from the gut into intestinal capillaries, and low-grade portal venous endotoxemia is the status quo. Under physiologic conditions, Kupffer cells of the liver totally phagocytize and degrade endotoxin from the portal circulation. Evidence from this and other laboratories indicates that administration of exogenous LPS to humans and rats enhances pancreatic secretion of both insulin and glucagon. Conversely, findings of the present study demonstrate that restriction of endogenous LPS in fasted rats depresses the basal and arginine-stimulated concentrations of plasma insulin. Techniques used to restrict gut-derived LPS availability included chronic daily ga^ge with neomycin and cefazolin for gut sterilization and with cholestyramine or lactulose to reduce endotoxin within the gut, In addition, induction of endotoxin tolerance was produced by progressively higher doses of LPS intraperitoneally (i.p.), and polymyxin B was administered subcutaneously (s.c.) daily to neutralize the lipid A portion of circulating LPS. Finally, isolator-reared, defined flora rats, which were gram-negative-bacteria-deficient, and, therefore, LPSdeficient, were compared with conventional counterparts. Basal plasma insulin but not glucagon levels were consistently and significantly reduced in endogenous LPS-restricted animals. Glucose-stimulated plasma insulin was decreased only after parenteral treatment by tolerance induction and polymyxin B administration. Both plasma insulin and glucagon were depressed in response to arginine challenge in most LPS-restricted rats. Findings of this and previous studies suggest that routine phagocytosis of portal endotoxin by hepatic Kupffer cells releases humoral factors such as interleukin-1 to tonically prime the physiologic 
A recent publication by this laboratory noted that the basal portal and systemic venous plasma levels of insulin but not glucagon in 24-h-fasted rats are significantly reduced after induction of endotoxin tolerance by intraperitoneal (i.p.) administration of progressively higher doses of bacterial lipopolysaccharide (LPS) and after gut sterilization by chronic ingestion of the poorly absorbed antibiotics neomycin sulfate and cefazolin sodium in drinking water. 1 Reference was made in that article to the earlier work of Sewell et al., 2 who determined the basal and glucose-stimulated systemic insulin concentrations in fasted germ-free rats. These investigators reported that basal as well as 30 min postchallenge with intravenous (i.v.) glucose values of plasma insulin are depressed in 100-day-old germfree rats compared with conventional control rats. Similar to the findings of Rayfield et al. 3 in humans and of Buchanan and Filkins 4 among others in rats, this laboratory has published evidence that i.v. administration of a low, nonlethal dose of exogenous endotoxin to 24-h-fasted rats elevates the plasma concentrations of both insulin and glucagon within 4 h post-LPS injection. 5 Elevation of the portal venous levels of both hormones indicates enhanced pancreatic secretion through a yet unidentified mechanism.
The contrast between elevation of pancreatic hormones after exogenous endotoxin administration and depression of insulin in rats, which probably had an endogenous endotoxin deficiency due to tolerance induction, gut sterilization, or germ-free status, suggests that gut-derived endotoxin tonically primes pancreatic secretion of insulin in normal animals. The purpose of this study is to test that hypothesis. Two wellknown investigators in the field of liver disease and endotoxemia, Nolan 6 and Liehr 7 , have reviewed evidence that modification of gut-derived endotoxicity by a variety of meth-ods reduces the severity of experimental liver damage in laboratory animals. Several of these methods will be used to restrict endotoxin availability from the gut in order to evaluate the basal, glucose-stimulated, and arginine-stimulated plasma insulin and glucagon responses in endogenous LPSdeficient rats compared with appropriate controls. The reason for using the terminology to restrict rather than to elimU nate completely the availability of gut-derived endogenous endotoxin is because, as described by Grun et al., 8 even germ-free animals possess enteric endotoxin due to the ubiquitous presence of LPS in food and water.
MATERIALS AND METHODS
Animals. Male Holtzman rats (Madison, Wisconsin) weighing 240-300 g were maintained at 76°F on 12-h light-dark cycles with Purina laboratory chow and water ad libitum for 1 wk before experimentation. All experiments were initiated between 0800 and 1200 h in order to eliminate the influence of diurnal variations in plasma hormone levels. Endotoxin administration. Rats were fasted for 24 h before endotoxin administration and plasma sampling for insulin and glucagon determination in order to deplete hepatic glycogen. Lipopolysaccharide was the Boivin preparation from Salmonella enteritidis (Difco, Detroit, Michigan), which was suspended daily in sterile isotonic saline with the vehicle as the control. Exogenous endotoxin was injected i.v. at a dose of 33 (xg/100 g via the dorsal vein of the penis to lightly etheranesthetized animals. Restriction of endotoxin availability. To examine the role of endogenous gut-derived endotoxin in pancreatic secretion of both insulin and glucagon, a variety of techniques was used to restrict the availability of enteric LPS. Rats were gavaged daily for 7 days with neomycin sulfate (10 mg; Upjohn, Kalamazoo, Michigan) and cefazolin sodium (5 mg; SmithKline, Philadelphia, Pennsylvania) to sterilize the gut, thus eliminating the gram-negative bacteria source of endotoxin. Another group had endotoxin (0.5 mg) included in the daily treatment with neomycin and cefazolin to replace the enteric LPS. Gavage daily for 7 days with cholestyr.amine (150 mg; Mead Johnson, Evansville, Indiana) or with lactulose (1.33 g; Merrell DoW, Cincinnati, Ohio) was used to reduce endotoxin within the gut. The control group for the above treatments was gavaged daily for 7 days with 2 ml of distilled water. Induction of tolerance was produced by daily i.p. injections of progressively higher doses of endotoxin (0.01-1.0 mg) for 7 days with the last dose administered 72 h before testing. The endotoxin already absorbed into the circulation from the gut was neutralized with daily s.c. administration of the antiendotoxin antibiotic polymyxin B (0.5 mg; Burroughs-Wellcome, Research Triangle Park, North Carolina) for 7 days. The control group for tolerance-induced and polymyxin Binjected animals was administered sterile isotonic saline i.p. daily for 7 days. Finally, isolator-reared, defined flora, male Fisher rats, which were gram-negative-bacteria-deficient and, therefore, LPS-deficient, were obtained from the Harlan Sprague-Dawley Company (Indianapolis, Indiana). Conventional male Fisher animals weighing -120 g served as controls. The Fisher rats were shipped with autoclaved potatoes, which were removed from the sterile containers immediately after arrival, apd the animals fasted for 24 h before testing.
Determination of glucose, insulin, and glucagon. Rats were fasted for 24 h after the last gavage or injection with water ad libitum. Test solutions were prepared by dissolving D-glucose (Fisher, Fair Lawn, New Jersey) and L-arginine hydrochloride (Sigma, St. Louis, Missouri) in sterile isotonic saline with the pH pf the latter solution adjusted to 7.4. DGlucose (100 mg/100 g) or L-arginine (40 mg/100 g) was administered i.v. into pentobarbital-anesthetized animals, and glucose-or arginine-stimulated insulin and glucagon levels were determined at 5 min postinjection for portal and systemic venous plasma samples. Basal or poststimulation portal and systemic (inferior vena cava) blood samples were collected in ice-cold tubes containing EDTA (1.2 mg/ml) and Trasylol(500KIU/ml)andcentrifugedat 1500 x g for 20 min at 4°C. Platelet-poor plasma samples were stored frozen at -30°C until the determination of glucose, insulin, and glucagqn. Systemic plasma glucose concentrations were measured with a Yellow Springs model 23A glucose analyzer (Yellow Springs, Ohio). Immunoreactive insulin and glucagon were quantified in portal and systemic plasma samples with radioimmunoassay kits from Cambridge Diagnostics (Billerica, Massachusetts) as described previously by this laboratory. 15 Porcine hormones provided with the kits were used for standards. Data analysis. Data are expressed as the mean ± standard error of the mean (SE) with the number of rats (N) per group indicated. The data were compared by the unpaired Student Mest or one-way analysis of variance with mean separation performed using the Student-Newman-Keuls test. The confidence level was set at 95% for all experiments.
RESULTS
Administration of exogenous endotoxin at a low, nonlethal dose of 33 |xg/100 g i.v. to 24-h-fasted rats significantly elevated the basal as well as glucose-and arginine-stimulated portal and systemic plasma insulin and glucagon concentrations at 4-h post-LPS injection (except glucagon postglucose) compared with the values for saline control animals (Table 1) . No changes in systemic plasma glucose levels were noted between experimental and control rats. These findings indicate that bacterial endotoxin elicits enhanced pancreatic secretion of both insulin and glucagon under basal conditions as well as after glucose and arginine stimulation through a yet unidentified mechanism.
Because administration of exogenous endotoxin stimulated pancreatic hormonal secretion, we speculated that restriction of endogenous gut-derived LPS would depress plasma insulin and/or glucagon concentrations. Therefore, a variety of techniques were employed to restrict the availability of endogenous endotoxin in order to test this hypothesis.
As can be seen in Table 2 , separate gavage control and injection control animals had similar basal plasma glucose, insulin, and glucagon concentrations that were, therefore, combined into a single control group, with N = 30. Gut-sterilization with neomycin and cefazolin resulted in a significant depression of basal portal and systemic insulin, but not of glucagon levels, which was prevented by the addition of exogenous endotoxin to the daily antibiotic gavage. Portal and systemic glucagon levels actually increased due to oral endotoxin treatment. Chronic gavage with cholestyramine or Data are expressed as means ± SE, with the number of rats per group given in parentheses. Holtzman rats fasted for 24 h were administered endotoxin (33 ng/100 g) or sterile isotonic saline as a control via the dorsal vein of the penis. At 4 h postendotoxin, D-glucose (100 mg/ 100 g) or L-arginine (40 mg/100 g) was injected i.v. into pentobarbital-anesthetized animals. Basal, glucose-stimulated, or aginine-stimulated insulin and glucagon levels were determined at 5 min postglucose or postarginine for portal and systemic venous plasma samples. *P < 0.05 compared with appropriate saline control group by unpaired Student's f-test.
lactulose to reduce LPS within the gut caused significant decreases in portal and systemic concentrations of both insulin and glucagon. Parenteral treatment with endotoxin for tolerance induction and with polymyxin B to neutralize the circulating LPS caused a significant depression of plasma insulin but not glucagon levels. The consistent alteration noted in these experiments was that restriction of endogenous gut-derived endotoxin by a variety of methods significantly decreased the basal plasma levels of the pancreatic hormone insulin. Examination of Table 3 reveals that in response to glucose stimulation, plasma insulin levels were not significantly depressed in endotoxin-restricted animals, except for those treated by induction of endotoxin tolerance and administra- Data are expressed as means ± SE, with the number of rats per group given in parentheses. For 7 consecutive, days, Hoitzman rats were gavaged with water (2.0 ml/day) as a control, neomycin sulfate (10 mg/day), and cefazolin sodium (5 mg/day) for gut-sterilization with and without added endotoxin (0.5 mg/day), cholestyramine (150 mg/day), or lactulose (1.33 g/day) or injected with sterile isotonic saline (0.5 ml/day) as a control, increasing doses of endotoxin (0.01-1.0 mg/day i.p.) for endotoxin tolerance, or polymyxin B (0.4 mg/day s.c). Rats were then fasted for 24 h after the last gavage or injection with water ad libitum. Basal insulin and glucagon levels were determined for portal and systemic venous plasma samples from pentobarbital-anesthetized animals. *P < 0.05 compared with composite control group by analysis of variance. Data are expressed as means ± SE, with the number of rats per group given in parentheses. For 7 consecutive days, Holtzman rats were gavaged with water (2.0 ml/day) as a control, neomycin sulfate (10 mg/day), and cefazolin sodium (5 mg/day) for gut-sterilization with and without added endotoxin (0.5 mg/day), cholestyramine (150 mg/day), or lactulose (1.33 g/day) or injected with sterile isotonic saline (0.5 ml/day) as a control, increasing doses of endotoxin (0.01-1.0 mg/day i.p.) for endotoxin tolerance, or polymyxin B (0.4 mg/day s.c.) Rats were then fasted for 24 h after the last gavage or injection with water ad libitum. D-Glucose (100 mg/100 g) was administered i.v. into pentobarbital-anesthetized animals, and glucose-stimulated insulin and glucagon levels were determined at 5-min postglucose for portal and systemic venous plasma samples. *P < 0.05 compared with composite control group by analysis of variance.
tion of polymyxin B. Thus, while gavage methods failed to influence glucose-stimulated insulin secretion by the pancreas, the parenteral treatments of tolerance induction and antiendotoxin antibiotic administration did impair pancreatic insulin secretion in response to glucose similar to the findings for basal insulin levels. The data of Table 4 indicate that pancreatic hormone levels in response to arginine stimulation in endotoxin-restricted rats were more similar to the basal values than to those for glucose stimulation. Arginine-stimulated portal and systemic plasma concentrations of both insulin and glucagon were significantly reduced in gut-sterilized animals compared with the combined control values. Addition of exogenous endotoxin to the daily antibiotic gavage prevented the decrease in portal insulin only. Chronic gavage with cholestyramine or lactulose to reduce LPS within the gut caused significant decreases in portal and systemic concentrations of insulin but not glucagon. Parenteral treatment with endotoxin for tolerance induction and with polymyxin B resulted in a significant depression of both portal insulin and glucagon levels. The difference in the pancreatic hormonal response for animals with restriction of endogenous endotoxin between glucose and arginine stimulation is not known.
Finally, the basal as well as glucose-and arginine-stimulated plasma insulin and glucagon concentrations were determined in defined flora Fisher rats and their conventional counterparts (Table 5) . Basal plasma insulin levels were lower in the isolator-reared animals, with a significant decrease of the portal value. Basal glucagon as well as glucose-stimulated levels of both insulin and glucagon and arginine-stimulated levels of glucagon were not significantly different in defined flora rats compared with conventional control rats. Unexpectedly, the portal insulin level in control rats did not increase above the basal value in response to arginine challenge. The systemic insulin concentrations after arginine stimulation were different between defined flora and control animals but not to the level of significance. The bacteriadeficient nature of the defined flora Fisher rats was demonstrated by the finding that the liver-to-body weight percentage of 2.38 ± 0.041% (N = 21) for the isolator-reared animals was significantly (P < 0.01) less than the value of 2.80 ± 0.032% (N = 21) for conventional Fisher rats.
DISCUSSION
Endogenous endotoxin is continually produced within the gut of normal animals by the death of gram-negative bacteria and absorbed into intestinal capillaries so that low-grade portal venous endotoxemia is the status quo for humans and probably other mammals. 910 Under physiologic circumstances, LPS is totally cleared from the portal circulation and subsequently degraded with lysosomal enzymes by the hepatic Kupffer cells, which constitute the major population of reticuloendothelial system (RES) macrophages.
1112 Thus, the systemic blood but not the portal blood is usually devoid of LPS due to active phagocytosis by Kupffer cells of the liver.
The purpose of this study is to test the hypothesis that restriction of gut-derived endotoxin diminishes pancreatic hormone concentrations under basal and stimulated conditions in fasted rats. To accomplish this task, a variety of techniques was employed to restrict endogenous LPS availability. Evidence from previous investigations concerning the efficacy of these techniques is described below. Data are expressed as means ± SE, with the number of rats per group given in parentheses. For 7 consecutive days, Holtzman rats were gavaged with water (2.0 ml/day) as a control, neomycin sulfate (10 mg/day), and cefazolin sodium (5 mg/day) for gut-sterilization with and without added endotoxin (0.5 mg/day), cholestyramine (150 mg/day), or lactulose (1.33 g/day), or injected with sterile isotonic saline (0.5 ml/day) as a control, increasing doses of endotoxin (0.01-1.0 mg/day i.p.) for endotoxin tolerance, or polymyxin B (0.4 mg/day s.c).
Rats were then fasted for 24 h after the last gavage or injection with water ad libitum. L-Arginine (40 mg/100 g) was administered i.v. into pentobarbital-anesthetized animals, and arginine-stimulated insulin and glucagon levels were determined at 5-min postarginine for portal and systemic venous plasma samples. *P < 0.05 compared with composite control group by analysis of variance.
The classic studies of Broitman et al. 13 and Fine 14 used chronic ingestion of poorly absorbed antibiotics such as neomycin in the drinking water to demonstrate a role for gutderived endotoxin in the development of choline deficiency cirrhosis in rats. The former investigators added LPS back into the drinking water along with neomycin, similar to the addition of endotoxin to gavage fluid in the present study. Neomycin and cefazolin were administered by daily gavage in the present study to ensure consistent drug dosages. Cefazolin was included in the gavage fluid to eliminate any anaerobic bacteria not affected by neomycin. Prior mixing of cholestyramine with LPS reduces both the lethality of endo -TABLE 5 Basal, glucose-stimulated, and arginine-stimulated pancreatic hormonal levels in defined flora (gram-negative-bacteria-deficient) fasted rats Cr-labeled endotoxin across the everted rat gut sac preparation according to Nolan and AIL 15 Furthermore, Liehr et al. 16 described lactulose as an antiendotoxin drug that reduces enteric LPS. Again, cholestyramine and lactulose were given by daily gavage in the present study to ensure consistent drug dosages. Chronic gavage for 7 days was deemed necessary in these experiments because Goto and Nakamura 17 and others have reported that acute antibiotic treatment may actually increase gut-derived endotoxin availability.
Induction of endotoxin tolerance is effective due probably to a combination of humoral factors, i.e., anti-LPS immunoglobulins, and cellular factors, i.e., enhanced RES phagocytosis of endotoxin. 18 The mechanism of LPS tolerance, however, may not be primarily dependent on accelerated clearance by the RES, but rather may involve a loss of the ability to produce or secrete mediator(s). Tolerance to endotoxin has been associated with impaired endogenous pyrogen release from hepatic Kupffer cells. 19 Regarding polymyxin B, Rifkind 20 described decreased lethality due-to i.v. endotoxin injection if the animals were pretreated with the antiendotoxin antibiotic. Nolan 6 has suggested that polymyxin B neutralizes the highly toxic lipid A portion of circulating LPS. Administration of antibiotics, including polymyxin B, for as short as 3 consecutive days can significantly depress RES phagocytic activity in rats by preventing the tonic stimulation of macrophages with endogenous bacteria and/ or bacterial products according to Altura and Gebrewold. 21 Several investigators have noted significant reductions in certain potentially gut-influenced parameters in germ-free or pathogen-free animals, similar to the effect of antibiotics, including decreased liver weight by Gordon et al., 22 diminished liver enzyme content by Reveley et al., 23 and depressed hepatic Kupffer cell phagocytic capacity by Altura 24 and Grun et al. 8 A lack of tonic stimulation by gut-derived bacteria and/ or bacterial products, i.e., endogenous endotoxin, was cited by all these investigators as the probable cause for the observed reductions. In the present study, a decreased liverto-body weight ratio was demonstrated for isolator-reared, defined flora Fisher rats in comparison to that of weightmatched, conventional control rats.
A variety of techniques to restrict gut-derived LPS availability in this investigation consistently and significantly depressed the basal and arginine-stimulated plasma insulin levels in fasted rats. Results for plasma glucagon in LPSrestricted animals were not consistent except, perhaps, for depression in response to arginine challenge and, therefore, are not emphasized as a significant finding of this study. Glucose-stimulated plasma insulin concentrations were only decreased in rats with parenteral treatment by tolerance induction and polymyxin B administration. A possible explanation for this finding is that gavage with antibiotics, cholestyramine, and lactulose may not have effectively eliminated the LPS present in food and water, as noted by Grun et al., 8 while parenteral treatment was more successful in neutralizing both enteric and ingested endotoxin, which had been absorbed into the portal circulation. Among others, Gerich et al. 25 and Shah 26 have demonstrated that glucose and arginine elicit pancreatic hormonal secretion via different mechanisms, thus providing a potential explanation for the discrepancy between glucose-and arginine-stimulated alterations of plasma insulin in LPS-restricted rats. The fact that Sewell et al. 2 observed a depression of plasma insulin at 30 min after glucose challenge in germ-free rats cannot be reconciled with the present data, indicating no significant difference between plasma insulin levels at 5 min after glucose challenge in defined flora rats compared with conventional controls.
The mechanism of exogenous endotoxin-induced hyperinsulinemic and hyperglucagonemic responses is as yet unknown, but Yelich and Filkins 27 have reported enhanced secretion of insulin by the isolated perfused pancreata of LPStreated rats. These investigators speculated that perhaps one of the many humoral factors, i.e., monokines, released by RES macrophages in response to phagocytosis, as enumerated recently by Takemura and Werb, 28 may be responsible for the enhanced pancreatic insulin secretion. In fact, phagocytosis of endotoxin triggers the release by macrophages, particularly hepatic Kupffer cells, of endogenous pyrogen/ leukocytic endogenous mediator/interleukin-1, and i.p. administration of a crude interleukin-1 preparation into rats significantly elevates plasma insulin and glucagon concentrations according to George et al. 29 Conversely, a direct effect of LPS on the pancreas to enhance insulin secretion was not supported by recent in vitro experiments with isolated, perfused pancreata of normal rats. 30 An alternative to enhanced pancreatic secretion as an explanation of the hyperinsulinemia in endotoxin-treated rats is depressed removal of insulin by the liver. However, Abernathy et al. 31 noted that hepatic insulin receptors actually increase in response to chronic LPS administration to rats, and Yelich and Filkins 27 found no change in insulin uptake by the isolated, perfused livers of endotoxin-treated rats compared with control animals.
The situation for endogenous endotoxin-restricted animals can at the present time only be interpreted in view of the above findings for exogenous endotoxin-treated rats and the data of this investigation. Because low-grade portal venous endotoxemia is the status quo for normal animals, perhaps continual phagocytosis of endogenous LPS by hepatic Kupffer cells triggers ongoing release of interleukin-1 to tonically prime beta cells of the pancreas to secrete the usual physiologic amount of insulin. Restriction of gut-derived endotoxin availability, as in the present study, would thus reduce or eliminate the priming influence of endogenous LPS through interleukin-1 and in turn account for the significant depression of plasma insulin. Because exogenous LPS administration increases hepatic insulin receptors in rats, perhaps endogenous LPS restriction decreases insulin receptors of the liver. However, a reduction of hepatic insulin receptors in endogenous LPS-restricted rats does not explain the depression of plasma insulin in these animals. Therefore, the most reasonable explanation for the findings of the present study is that endogenous gut-derived bacterial endotoxin tonically primes pancreatic secretion of insulin in normal rats.
